# GelSana awarded $1.25M AFWERX Phase II SBIR contract for wound healing polymers

GelSana Therapeutics was awarded a $1.25 million Phase II SBIR contract by AFWERX to develop novel polymers for enhanced wound healing in combat-related burn injuries. The company will collaborate with Walter Reed Medical Center.

- Type: Contract
- Announced: 2024-04-10
- Where: Aurora, Colorado, United States
- Value: $1.25M
- Status: announced
- Products: novel polymers for wound healing
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [AFWERX](https://endata.com/companies/54826.md) (customer)
- [GelSana Therapeutics](https://endata.com/companies/76770.md) (supplier)

## Sources

- [gelsanatherapeutics.com](https://gelsanatherapeutics.com/2024/04/11/gelsana-awarded-an-afwerx-phase-ii-sbir-contract-to-develop-novel-polymers-for-enhanced-wound-healing-in-combat-related-burn-injuries/), 2024-04-11: "We are honored to have received this contract from AFWERX to develop our unique polymers for combat-related burn injuries."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.